Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 81 | CGON | CG ONCOLOGY INC | Healthcare | 20,000.0 | $1.4M | 0.06% | -150K | -88.2% | $67.68 | -5.1% |
| 82 | NEO | NEOGENOMICS INC | Healthcare | 175,000.0 | $1.3M | 0.05% | -253K | -59.1% | $7.42 | +24.4% |
| 83 | QNRX | QUOIN PHARMACEUTICALS LTD | Healthcare | 72,730.0 | $480K | 0.02% | +48K | +190.9% | $6.60 | -27.7% |
| 84 | COGT | COGENT BIOSCIENCES INC | Healthcare | 10,000.0 | $385K | 0.02% | -110K | -91.7% | $38.49 | -15.1% |
| 85 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 10,000.0 | $383K | 0.02% | -115K | -92.0% | $38.30 | -15.2% |
| 86 | STAA | STAAR SURGICAL CO | Healthcare | 20,000.0 | $374K | 0.01% | -5K | -20.0% | $18.70 | +73.6% |
| 87 | ANAB | ANAPTYSBIO INC | Healthcare | 6,000.0 | $333K | 0.01% | -129K | -95.6% | $55.46 | +7.7% |
| 88 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 10,000.0 | $313K | 0.01% | NEW | — | $31.29 | +20.5% |
| 89 | RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | 10,000.0 | $270K | 0.01% | -290K | -96.7% | $27.04 | +7.3% |
| 90 | — | ZYMEWORKS INC | — | 10,000.0 | $250K | 0.01% | -90K | -90.0% | $25.04 | — |
| 91 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 10,000.0 | $247K | 0.01% | — | — | $24.66 | +14.0% |
| 92 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 5,000.0 | $245K | 0.01% | -185K | -97.4% | $49.05 | +23.6% |
| 93 | — | JASPER THERAPEUTICS INC | — | 276,312.0 | $242K | 0.01% | +76K | +38.2% | $0.88 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%